Longevity of pimonidazole adducts in spontaneous canine tumors as an estimate of hypoxic cell lifetime

Radiation Research

Volumn 148, Issue 1, 1997, Pages 35-42

  Azuma, Chieko ^a   Raleigh, James A ^b   Thrall, Donald E ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PIMONIDAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN DETECTION; ARTICLE; CANCER RADIOTHERAPY; CONTROLLED STUDY; DOG; HYPOXIC CELL; LONGEVITY; NONHUMAN; PRIORITY JOURNAL; SOLID TUMOR;

ANIMALS; ANOXIA; CELL SURVIVAL; DNA ADDUCTS; DNA, NEOPLASM; DOG DISEASES; DOGS; NEOPLASMS; NITROIMIDAZOLES;

EID: 0031008710     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.2307/3579536     Document Type: Article

References (54)

1. J. Moulder and S. Rockwell, Hypoxic fractions of solid tumors: Experimental techniques, methods of analysis, and a survey of existing data. Int. J. Radiat. Oncol. Biol. Phys. 10, 695-712 (1984).
2. J. M. Cline, E. M. Zeman, D. E. Thrall and J. A. Raleigh, Immunohistochemical detection of a hypoxia marker in spontaneous canine tumours. Br. J. Cancer 62, 925-931 (1990).
3. J. M. Cline, D. E. Thrall, G. L. Rosner and J. A. Raleigh, Distribution of the hypoxia marker CCI-103F in canine tumors. Int. J. Radiat. Oncol. Biol. Phys. 28, 921-933 (1994).
4. R. A. Gatenby, H. B. Kessler, J. S. Rosenblum, L. R. Coia, P. J. Moldofsky, W. H. Hartz and G. J. Broder, Oxygen distribution in squamous cell carcinoma metastases and its relationship in outcome of radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 14, 831-838 (1988).
5. D. M. Brizel, G. L. Rosner, J. Harrelson, L. R. Prosnitz and M. W. Dewhirst, Pretreatment oxygenation profiles of human soft tissue sarcomas. Int. J. Radiat. Oncol. Biol. Phys. 30, 635-642 (1994).
6. D. Brizel, G. Rosner, L. Prosnitz and M. Dewhirst, Patterns and variability of tumor oxygenation in human soft tissue sarcomas, cervical carcinomas and lymph node metastases. Int. J. Radiat. Oncol. Biol. Phys. 32, 1121-1125 (1995).
7. 2 tension measurements. Cancer Res. 51, 6098-6102 (1991).
8. E. Lartigau, A. Le Ridant, P. Lambin, P. Weeger, L. Martin, R. Sigal, A. Lusinchi, B. Lubonski, F. Eschwege and M. Guichard, Oxygenation of head and neck tumors. Cancer 71, 2319-2325 (1993).
9. M. Nordsmark, S. Bentzen and J. Overgaard, Measurement of human tumour oxygenation status by a polarographic needle electrode. An analysis of inter-and intratumor heterogeneity. Acta Oncol. 33, 383-389 (1994).
10. 2 tension measurements. Cancer Res. 51, 3316-3322 (1991).
11. R. H. Thomlinson and L. H. Gray, The histological structure of some human lung cancers and the possible implications for radiotherapy. Br. J. Cancer 9, 539-549 (1955).
12. J. M. Brown, Evidence for acutely hypoxic cells in mouse tumours and a possible mechanism of reoxygenation. Br. J. Cancer 52, 650-656 (1979).
13. D. Chaplin, P. Olive and R. E. Durand, Intermittent blood flow in a murine tumor: Radiobiological effects. Cancer Res. 47, 597-601 (1987).
14. M. W. Dewhirst, T. W. Secomb, E. T. Ong, R. Hsu and J. F. Gross, Determination of local oxygen consumption rates in tumors. Cancer Res. 54, 3333-3336 (1994).
15. E. J. Hall, Radiobiology for the Radiologist, 3rd ed., pp. 137-160. J. B. Lippincott, Philadelphia, 1988.
16. J. A. Raleigh, M. W. Dewhirst and D. E. Thrall, Measuring tumor hypoxia. Semin. Radiat. Oncol. 6, 37-45 (1996).
17. 2 predicts survival in advanced cancer of the uterine cervix. Radiother. Oncol. 26, 45-50 (1993).
18. M. Nordsmark, M. Overgaard and J. Overgaard, Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother. Oncol. 41, 31-39 (1996).
19. M. Höckel, K. Schlenger, M. Mitze, U. Schäffer and P. Vaupel, Hypoxia and radiation response in human tumors. Semin. Radiat. Oncol. 6, 3-9 (1996).
20. L. van Putten and R. Kallman, Tumour reoxygenation during fractionated radiotherapy: Studies with a transplantable osteosarcoma. Eur. J. Cancer 4, 173-182 (1968).
21. D. E. Thrall, M. C. McEntee, J. M. Cline and J. A. Raleigh, ELISA quantification of CCI-103F in canine tumors prior to and during irradiation. Int. J. Radiat. Oncol. Biol. Phys. 28, 649-659 (1994).
22. R. E. Durand, The influence of microenvironmental factors on the activity of radiation and drugs. Int. J. Radiat. Oncol. Biol. Phys. 20, 253-258 (1991).
23. T. G. Graeber, C. Osmanian, T. Jacks, D. E. Housman, C. J. Koch, S. W. Lowe and A. J. Giaccia, Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379, 88-91 (1996).
24. D. Shweiki, A. Itin, D. Soffer and E. Keshet, Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359, 843-845 (1992).
25. R. M. Sutherland, W. A. Ausserer, B. J. Murphy and K. R. Laderoute, Tumor hypoxia and heterogeneity: Challenges and opportunities for the future. Semin. Radiat. Oncol. 6, 59-70 (1996).
26. A. Giaccia, Hypoxic stress proteins: Survival of the fittest. Semin. Radiat. Oncol. 6, 46-58 (1996).
27. J. A. Raleigh, A. J. Franko, E. O. Treiber, J. A. Lunt and P. S. Allen, Covalent binding of fluorinated 2-nitroimidazole to EMT-6 tumors in BALB/C mice. Detection by F-19 nuclear magnetic resonance at 2.35T. Int. J. Radiat. Oncol. Biol. Phys. 12, 1249-1251 (1986).
28. J. A. Raleigh, G. G. Viller, A. J. Franko, C. J. Koch, A. F. Fuciarelli and D. A. Kelly, Fluorescence immunohistochemical detection of hypoxic cells in spheroids and tumours. Br. J. Cancer 56, 395-400 (1987).
29. 19F magnetic resonance method for measuring oxygen deficiency in tumors. Magn. Reson. Med. 22, 451-466 (1991).
30. J. A. Raleigh, J. K. La Dine, J. M. Cline and D. E. Thrall, An enzyme-linked immunosorbent assay for hypoxia marker binding in tumours. Br. J. Cancer 69, 66-71 (1994).
31. J. D. Chapman, A. J. Franko and J. Sharplin, A marker for hypoxic cells in tumours with potential clinical applicability. Br. J. Cancer 43, 546-550 (1981).
32. J. D. Chapman, K. Baer and J. Lee, Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells. Cancer Res. 43, 1523-1528 (1983).
33. 3H-misonidazole to solid human tumors as a measure of tumor hypoxia. Int. J. Radiat. Oncol. Biol. Phys. 12, 1263-1267 (1986).
34. W. Mueller-Kleisser, H. Schlenger, S. Walenta, M. Gross, U. Karbach, U. Hoecker and P. Vaupel, Pathophysiological approaches to identifying tumor hypoxia in patients. Radiother. Oncol. 20 (Suppl.), 21-28 (1991).
35. C. E. Smithen and C. R. Hardy, The chemistry of nitroimidazole hypoxic cell radiosensitizers. In Advanced Topics on Radiosensitizers of Hypoxic Cells (A. Breccia, C. Rimondi and G. E. Adams, Eds.), pp. 1-47. Plenum Press, New York, 1982.
36. J. K. Inman, Thymus-independent antigens: The preparation of covalent hapten-Ficoll conjugates. J. Immunol. 114, 704-709 (1975).
37. J. A. Raleigh and C. H. Koch, Importance of thiols in the reductive binding of 2-nitroimidazoles to macromolecules. Biochem. Pharmacol. 40, 2457-2464 (1990).
38. D. E. Thrall, G. L. Rosner, C. Azuma, M. C. McEntee and J. A. Raleigh, Hypoxia marker labeling in tumor biopsies: Quantification of labeling variation and criteria for biopsy sectioning. Radiother. Oncol., in press.
39. I. F. Tannock, Oxygen diffusion and the distribution of cellular radiosensitivity in tumours. Br. J. Radiol. 45, 515-524 (1972).
40. D. G. Hirst and J. Denekamp, Tumour cell proliferation in relation to the vasculature. Cell Tissue Kinet. 12, 31-42 (1979).
41. I. Tannock, Oxygen distribution in tumours: Influence on cell proliferation and implications for tumour therapy. Adv. Exp. Med. Biol. 75, 597-603 (1976).
42. I. F. Tannock, A comparison of cell proliferation parameters in solid and ascites Ehrlich tumors. Cancer Res. 29, 1527-1534 (1969).
43. I. F. Tannock and G. G. Steel, Tumor growth and cell kinetics in chronically hypoxic animals. J. Natl. Cancer Inst. 45, 123-133 (1970).
44. U. Del Monte, Changes in oxygen tension in Yoshida ascites hepatoma during growth. Proc. Exp. Biol. Med. 125, 853-856 (1967).
45. R. W. Brosemer and W. J. Rutter, The effect of oxygen tension on the growth and metabolism of a mammalian cell. Exp. Cell Res. 25, 101-113 (1961).
46. G. E. Gifford, Some effects of anaerobiosis on the growth and metabolism of HeLa cells. Exp. Cell Res. 31, 113-118 (1963).
47. J. A. Raleigh, E. M. Zeman, D. P. Calkins, M. C. McEntee and D. E. Thrall, Distribution of hypoxia and proliferation associated markers in spontaneous canine tumors. Acta Oncol. 34, 345-349 (1995).
48. C. N. Coleman, T. H. Wasserman, R. C. Urtasun, J. Halsey, V. K. Hirst, S. Hancock and T. L. Phillips, Phase I trial of the hypoxic cell radiosensitizer SR-2508: The results of the five to six week drug schedule. Int. J. Radiat. Oncol. Biol. Phys. 12, 1105-1108 (1986).
49. J. M. Cline, G. L. Rosner, J. A. Raleigh and D. E. Thrall, Quantification of CCI-103F labeling heterogeneity in canine solid tumors. Int. J. Radiat. Oncol. Biol. Phys., in press.
50. M. Nordsmark, M. Hoyer, J. Keller, O. S. Nielsen, O. M. Jensen and J. Overgaard, The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas. Int. J. Radiat. Oncol. Biol. Phys. 35, 701-708 (1996).
51. A. S. Kennedy, J. A. Raleigh, G. M. Perez, D. P. Calkins, D. E. Thrall, D. B. Novotny and M. A. Varia, Proliferation and hypoxia in human squamous cell carcinoma of the cervix: First report of combined immunohistochemical assays. Int. J. Radiat. Oncol. Biol. Phys. 37, 897-905 (1997).
52. A. Hershko and A. Ciechanover, The ubiquitin system for protein degradation. Annu. Rev. Biochem. 61, 761-807 (1992).
53. J. A. Raleigh, A. J. Franko, C. J. Koch and J. L. Born, Binding of misonidazole to hypoxic cells in monolayer and spheroid culture: Evidence that a side-chain label is bound as efficiently as a ring label. Br. J. Cancer 51, 229-235 (1985).
54. B. Alberts, D. Bray, J. Lewis, M. Raff, K. Roberts and J. D. Watson, Molecular Biology of the Cell, 2nd ed. Garland Publishing, New York, 1989.